Order Article Reprints

Zhao Q, Bae E-H, Zhang Y, Shahsavari A, Lotey P, Lee RH, Liu F. Inhibitory Effects of Extracellular Vesicles from iPS-Cell-Derived Mesenchymal Stem Cells on the Onset of Sialadenitis in Sjögren’s Syndrome Are Mediated by Immunomodulatory Splenocytes and Improved by Inhibiting miR-125b. International Journal of Molecular Sciences. 2023; 24(6):5258. https://doi.org/10.3390/ijms24065258

Zhao, Qingguo, Eun-Hye Bae, Yu Zhang, Arash Shahsavari, Pranayvir Lotey, Ryang Hwa Lee, and Fei Liu. 2023. "Inhibitory Effects of Extracellular Vesicles from iPS-Cell-Derived Mesenchymal Stem Cells on the Onset of Sialadenitis in Sjögren’s Syndrome Are Mediated by Immunomodulatory Splenocytes and Improved by Inhibiting miR-125b" International Journal of Molecular Sciences 24, no. 6: 5258. https://doi.org/10.3390/ijms24065258

Zhao, Q., Bae, E.-H., Zhang, Y., Shahsavari, A., Lotey, P., Lee, R. H., & Liu, F. (2023). Inhibitory Effects of Extracellular Vesicles from iPS-Cell-Derived Mesenchymal Stem Cells on the Onset of Sialadenitis in Sjögren’s Syndrome Are Mediated by Immunomodulatory Splenocytes and Improved by Inhibiting miR-125b. International Journal of Molecular Sciences, 24(6), 5258. https://doi.org/10.3390/ijms24065258